Prospector Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-157,282
Closed -$13.2M 55
2025
Q3
$13.2M Sell
157,282
-9,521
-6% -$784K 1.58% 27
2025
Q2
$13.2M Sell
166,803
-10,499
-6% -$835K 1.51% 26
2025
Q1
$15.9M Sell
177,302
-1,036
-0.6% -$96.7K 1.79% 17
2024
Q4
$17.7M Buy
178,338
+15,490
+10% +$1.6M 1.97% 17
2024
Q3
$18.5M Buy
162,848
+737
+0.5% +$87.6K 1.93% 15
2024
Q2
$20.1M Buy
162,111
+1,064
+0.7% +$137K 2.24% 9
2024
Q1
$21.3M Buy
161,047
+2,860
+2% +$353K 2.34% 11
2023
Q4
$17.2M Buy
158,187
+610
+0.4% +$63.3K 2.15% 13
2023
Q3
$16.2M Buy
157,577
+515
+0.3% +$55.5K 2.18% 9
2023
Q2
$18.1M Sell
157,062
-2,875
-2% -$326K 2.53% 5
2023
Q1
$17M Sell
159,937
-17,365
-10% -$1.87M 2.37% 4
2022
Q4
$19.7M Sell
177,302
-17,486
-9% -$1.79M 2.69% 4
2022
Q3
$16.8M Sell
194,788
-5,420
-3% -$484K 2.5% 7
2022
Q2
$18.3M Sell
200,208
-10,000
-5% -$887K 2.66% 3
2022
Q1
$17.2M Sell
210,208
-13,500
-6% -$1.06M 2.13% 8
2021
Q4
$17.1M Sell
223,708
-3,400
-1% -$271K 1.98% 13
2021
Q3
$17.1M Buy
227,108
+1,560
+0.7% +$119K 2.19% 11
2021
Q2
$17.5M Sell
225,548
-15,280
-6% -$1.14M 2.21% 11
2021
Q1
$17.7M Buy
240,828
+9,170
+4% +$676K 2.27% 9
2020
Q4
$18.1M Buy
231,658
+62,094
+37% +$4.75M 2.25% 9
2020
Q3
$13.4M Buy
169,564
+6,550
+4% +$513K 2.02% 10
2020
Q2
$12M Sell
163,014
-11,633
-7% -$876K 2.09% 10
2020
Q1
$12.8M Buy
174,647
+17,501
+11% +$1.38M 2.42% 6
2019
Q4
$13.6M Buy
157,146
+1,258
+0.8% +$103K 1.91% 9
2019
Q3
$12.5M Sell
155,888
-22,846
-13% -$1.83M 1.83% 13
2019
Q2
$14.3M Buy
178,734
+419
+0.2% +$32.1K 1.96% 10
2019
Q1
$14.2M Sell
178,315
-18,550
-9% -$1.39M 2.15% 7
2018
Q4
$14.4M Buy
196,865
+524
+0.3% +$37K 2.24% 6
2018
Q3
$13.3M Buy
196,341
+2,515
+1% +$160K 1.83% 8
2018
Q2
$11.2M Buy
193,826
+15,616
+9% +$881K 1.57% 10
2018
Q1
$9.26M Sell
178,210
-2,935
-2% -$159K 1.35% 20
2017
Q4
$9.73M Buy
181,145
+11,843
+7% +$657K 1.42% 22
2017
Q3
$10.3M Buy
169,302
+21,798
+15% +$1.32M 1.57% 17
2017
Q2
$9.02M Buy
147,504
+43,492
+42% +$2.65M 1.42% 21
2017
Q1
$6.31M Sell
104,012
-314
-0.3% -$19.1K 0.96% 42
2016
Q4
$5.86M Buy
104,326
+42,444
+69% +$2.48M 0.87% 47
2016
Q3
$3.69M Sell
61,882
-31,755
-34% -$1.86M 0.59% 66
2016
Q2
$5.15M Sell
93,637
-50,199
-35% -$2.67M 0.87% 48
2016
Q1
$7.26M Buy
143,836
+4,716
+3% +$231K 1.25% 22
2015
Q4
$7.01M Sell
139,120
-108,468
-44% -$5.47M 1.25% 25
2015
Q3
$11.7M Sell
247,588
-10,794
-4% -$573K 1.68% 9
2015
Q2
$14M Sell
258,382
-335,360
-56% -$18.8M 1.66% 14
2015
Q1
$32.6M Buy
593,742
+3,039
+0.5% +$172K 2.45% 5
2014
Q4
$32M Sell
590,703
-114,337
-16% -$6.37M 2.43% 3
2014
Q3
$39.9M Sell
705,040
-1,153
-0.2% -$64.7K 2.19% 5
2014
Q2
$39M Sell
706,193
-1,886
-0.3% -$103K 1.87% 7
2014
Q1
$38.4M Sell
708,079
-23,790
-3% -$1.23M 1.83% 6
2013
Q4
$35M Buy
731,869
+520,804
+247% +$23.8M 1.56% 10
2013
Q3
$9.59M Buy
211,065
+61,832
+41% +$2.82M 0.44% 84
2013
Q2
$6.62M Buy
+149,233
New +$6.67M 0.33% 90

Other funds holding MRK

Prospector Partners's MRK Position: Q4 2025 in Review

Prospector Partners sold out of Merck (MRK) in Q4 2025, closing a stake of 157,282 shares — an estimated $13.2M sold.

Prospector Partners first reported a position in MRK in Q2 2013 and held it in 50 quarters. The position peaked at $39.9M in Q3 2014. 3,652 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Prospector Partners reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
  • Prospector Partners sold 157,282 Merck shares in Q4 2025, an estimated $13.2M.
  • Prospector Partners first reported a position in Merck in Q2 2013 and held it in 50 quarters.
  • Prospector Partners's Merck position peaked at $39.9M in Q3 2014.
  • 3,652 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Prospector Partners's 13F filing for Q4 2025, filed 13 Feb 2026.